Brief: BioPharma Credit Says Co's Allocation Of Financing Of Esperion Deal Between $78 Million And $120 Million
May 5 (Reuters) - BioPharma Credit PLC BPCR.L: BIOPHARMA CREDIT PLC - STATEMENT RE ARCHIMED BIOPHARMA CREDIT PLC - CO'S ALLOCATION OF FINANCING OF ESPERION DEAL BETWEEN $78 MILLION AND $120 MILLION Source text: ID:nRSE9090Ca Further company coverage: BPCR.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Esperion Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi